E3024 is a novel, selective and competitive dipeptidyl peptidase-IV inhibitor for the treatment of type 2 diabetes

被引：0
|
作者：
Yasuda, Nobuyuki
Nagakura, Tadashi
Inoue, Takashi
Yamazaki, Kazuto
Katsutani, Naruo
Takenaka, Osamu
Clark, Richard
Matsuura, Fumiyoshi
Emori, Eita
Yoshikawa, Seiji
Kira, Kazunobu
Okada, Toshimi
Ikuta, Hironori
Saeki, Takao
Asano, Osamu
Tanaka, Isao
机构：
来源：
DIABETES | 2006年 / 55卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：A349 / A349
页数：1
相关论文
共 50 条
  • [41] Alogliptin: a new, highly selective dipeptidyl peptidase-4 inhibitor for the treatment of type 2 diabetes
    Pratley, Richard E.
    EXPERT OPINION ON PHARMACOTHERAPY, 2009, 10 (03) : 503 - 512
  • [42] Linagliptin-A Novel Dipeptidyl Peptidase Inhibitor for Type 2 Diabetes Therapy
    Gallwitz, Baptist
    CLINICAL MEDICINE INSIGHTS-ENDOCRINOLOGY AND DIABETES, 2012, 5 : 1 - 11
  • [43] Dipeptidyl Peptidase IV Inhibitors: A New Paradigm in Type 2 Diabetes Treatment
    Janardhan, Sridhara
    Sastry, G. Narahari
    CURRENT DRUG TARGETS, 2014, 15 (06) : 600 - 621
  • [44] Therapeutic potential of dipeptidyl peptidase IV inhibitors for the treatment of type 2 diabetes
    Drucker, DJ
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2003, 12 (01) : 87 - 100
  • [45] Sixteen-Years of Clinically Relevant Dipeptidyl Peptidase-IV(DPP-IV) Inhibitors for Treatment of Type-2 Diabetes: A Perspective
    Kushwaha, R. N.
    Haq, W.
    Katti, S. B.
    CURRENT MEDICINAL CHEMISTRY, 2014, 21 (35) : 4013 - 4045
  • [46] Saxagliptin, a dipeptidyl peptidase IV inhibitor for the treatment of type 2 diabetes (vol 11, pg 906, 2008)
    Gallwitz, Baptist
    IDRUGS, 2009, 12 (03) : 200 - 200
  • [47] Discovery of carmegliptin: A potent and long-acting dipeptidyl peptidase IV inhibitor for the treatment of type 2 diabetes
    Mattei, Patrizio
    Boehringer, Markus
    Di Giorgio, Patrick
    Fischer, Holger
    Hennig, Michael
    Huwyler, Joerg
    Kocer, Buelent
    Kuhn, Bernd
    Loeffler, Bernd M.
    MacDonald, Alexander
    Narquizian, Robert
    Rauber, Etienne
    Sebokova, Elena
    Sprecher, Urs
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2010, 20 (03) : 1109 - 1113
  • [48] Metformin monotherapy versus dual therapy with metformin and a dipeptidyl peptidase-IV inhibitor for treatment of type 2 diabetes mellitus: a systematic review and meta-analysis
    Tobin-Schnittger, P.
    Ong, G.
    O'Brien, T.
    Liew, A.
    IRISH JOURNAL OF MEDICAL SCIENCE, 2016, 185 : 397 - 397
  • [49] Vildagliptin, a dipeptidyl peptidase-4 inhibitor, for the treatment of type 2 diabetes
    Stein, Stephanie A.
    Lamos, Elizabeth M.
    Davis, Stephen N.
    EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2014, 10 (04) : 599 - 608
  • [50] Linagliptin, a dipeptidyl peptidase-4 inhibitor for the treatment of type 2 diabetes
    Tiwari, Atul
    CURRENT OPINION IN INVESTIGATIONAL DRUGS, 2009, 10 (10) : 1091 - 1104
12345